An Extended Access Program (EAP) for Perampanel
- Conditions
- Primary Generalized Tonic-Clonic or Partial Onset SeizuresLennox Gastaut Syndrome
- Registration Number
- NCT02307578
- Lead Sponsor
- Eisai Inc.
- Brief Summary
The main objective of this EAP is to ensure that participants participating in Study E2007-G000-332, Study E2007-G000-311, E2007-G000-238, E2007-G000-338 or EAP E2007-G000-401 continue to have access to perampanel until such time that the appropriate formulation of perampanel becomes commercially available in the country in which they reside or until no participants remain in the EAP.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (27)
Cliniques Universitaires Saint-Luc
🇧🇪Brussels, Belgium
Hôpital Universitaire des Enfants Reine Fabiola
🇧🇪Brussels, Belgium
Centre Neurologique William Lennox
🇧🇪Ottignies, Belgium
Hospital Padre Hurtado
🇨🇱Santiago, Chile
Artroscan
🇨🇿Ostrava-Trebovice, Czechia
Všeobecná fakultní nemocnice, Pragtis s.r.o
🇨🇿Prague, Czechia
Oy Neurodiagnostika Ap
🇪🇪Tallinn, Estonia
Tartu University Hospital
🇪🇪Tartu, Estonia
Dél-Pesti Centrumkórház Országos Hematológiai és Infektológiai Intézet
🇭🇺Budapest, Hungary
Magyarorszagi Reformatus Egyhaz (MRE) Bethesda Gyermekkorhaza
🇭🇺Budapest, Hungary
Scroll for more (17 remaining)Cliniques Universitaires Saint-Luc🇧🇪Brussels, Belgium